MedTrace Logo

Study on the Efficacy and Safety of Gelaspan

NCT02808325 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2017-08-11

No results posted yet for this study

Summary

It is the objective of the study to investigate the efficacy and safety of two different volume replacement regimens with gelatine solutions.

Conditions

  • Hypovolemia

Interventions

DRUG

Gelaspan 4%

Gelaspan 4% combined with Sterofundin ISO

DRUG

Gelofusine 4%

Gelofusine 4% combined with Sodium Chloride

Sponsors & Collaborators

  • B. Braun Medical LLC

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2017-06-30
Completion
2017-06-30

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02808325 on ClinicalTrials.gov